Polysensitivity in delayed cutaneous adverse drug reactions to macrolides, clindamycin and pristinamycin: clinical history and patch testing

Br J Dermatol. 2018 Oct;179(4):978-979. doi: 10.1111/bjd.16738. Epub 2018 Jul 20.

Authors

M El Khoury¹, H Assier^{1

2}, G Gener^{1

2}, M Paul³, C Haddad¹, O Chosidow^{1

2

4

5}, P Wolkenstein^{1

2

4

5}, S Ingen-Housz-Oro^{1

2

4}

Affiliations

¹ Department of Dermatology, AP-HP, Henri Mondor Hospital, Créteil, France.
² Referral Center for Toxic Bullous Diseases and Severe Cutaneous Adverse Reactions, Créteil, France.
³ Department of Pharmacy, AP-HP, Henri Mondor Hospital, Créteil, France.
⁴ EA7379 EpidermE, UPEC, Créteil, France.
⁵ Université Paris Est Créteil Val de Marne UPEC, Créteil, France.

PMID: 29747236
DOI: 10.1111/bjd.16738

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents / adverse effects*
Clindamycin / adverse effects
Cross Reactions / drug effects
Cross Reactions / immunology
Drug Eruptions / diagnosis*
Drug Eruptions / etiology
Female
Humans
Macrolides / adverse effects
Male
Middle Aged
Patch Tests / methods*
Pristinamycin / adverse effects
Retrospective Studies
Skin / drug effects
Skin / immunology
Time Factors

Substances

Anti-Bacterial Agents
Macrolides
Pristinamycin
Clindamycin